Pricing Log in Create free account
Friday 6 November 2026 Export PVLA’s income statement to Excel — free account

Palvella Therapeutics, Inc.

PVLA Healthcare Biotechnology

Palvella Therapeutics, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $25.9 million.

EPS
−76.7%
Free cash flow
−136.4%

Quarter to June 2026, against a year earlier

174.63 17.78 +11.34%
Market cap
$2.3B
P/E
0.0×
Fwd P/E
−1.3×
Dividend yield
—
F-score
2/9
Altman Z
−11.49
Beneish M
1.44
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Palvella Therapeutics, Inc. (PVLA) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Palvella Therapeutics, Inc. (PVLA) trades at a P/S ratio of 54.1×. Over the past ten years it has ranged from 0.3× (July 2024) to 56.1× (November 2026); the current reading is higher than 100% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2023 0.6× (80.29%)
FY2022 3.1× (59.80%)
FY2021 7.8× 67.19%
FY2020 4.6× 17.30%
FY2019 4.0× (18.38%)
FY2018 4.9× (63.98%)
FY2017 13.5× 28.97%
FY2016 10.4× (61.12%)
FY2015 26.9× —

Quarterly newest first

Period P/S ratio Change
Mar 2024 0.6× 3.54%
Dec 2023 0.6× 3.50%
Sep 2023 0.6× 36.17%
Jun 2023 0.4× (89.88%)
33 more quarters

Against its own ten years

Low 0.3× High 56.1×
Ten-year median 7.4×
Current reading's percentile 100

P/S ratio against peers

Company P/S ratio
PHVS Pharvaris N.V. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
BHVN Biohaven Ltd. compare 2.1×
ADMA ADMA Biologics Inc compare 5.7×
AUPH Aurinia Pharmaceuticals Inc compare 6.7×
VCEL Vericel Corporation compare 8.1×
PVLA Palvella Therapeutics, Inc. 54.1×
IMNM Immunome, Inc. compare 162×
CLDX Celldex Therapeutics, Inc. compare 2,498×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on PVLA